Analyzing 490 complex scientific papers on zoonotic spillover cost just $26 using Anthropic's new Claude Science platform. This task would typically require weeks of human effort and incur thousands of dollars in expenses, according to Forbes. The new platform became available on Tuesday, as reported by Reuters and STAT.
Scientific research has historically been fragmented, costly, and time-consuming. Claude Science now offers a unified, high-performance, and remarkably inexpensive AI workbench for researchers. Claude Science fundamentally alters the economic accessibility of advanced scientific discovery.
Scientific discovery is likely to accelerate dramatically, shifting the focus from data gathering and initial analysis to deeper interpretation and experimental validation. However, new ethical and methodological challenges will emerge with this change.
What is Claude Science?
Anthropic's Claude Science is an AI workbench specifically designed for scientists. It integrates over 60 scientific databases and computation tools, according to Northeastern Global News. The comprehensive platform streamlines research by consolidating numerous disparate information sources and computational tools, moving beyond simple search to active analysis.
The platform's core value lies in its ability to unify previously fragmented resources. The integration drastically reduces the manual effort involved in accessing and cross-referencing information. It allows researchers to focus less on data retrieval and more on hypothesis generation and experimental design, fundamentally altering the initial stages of scientific inquiry.
Unifying Research and Driving Breakthroughs
Claude Science moves beyond mere data aggregation by consolidating fragmented research tools into a single reasoning layer, according to Genetic Engineering and Biotechnology News. The integration simplifies complex scientific workflows, replacing multiple software solutions with a unified AI-driven approach.
The platform's utility extends to specialized applications, exemplified by the inclusion of Basecamp Research's EDEN models. These models, crucial for antibiotic design and vaccine target prediction, are now accessible through Claude Science, Genetic Engineering and Biotechnology News reported. The integration empowers researchers to apply advanced AI to specific, high-stakes biological challenges.
The EDEN metagenomic foundation model achieved a 97% success rate in designing functional peptides effective against WHO critical-priority and multidrug-resistant pathogens, according to Genetic Engineering and Biotechnology News. The 97% success rate confirms AI's capacity to generate high-efficacy scientific solutions, not just process data. The platform's ability to host and leverage such specialized, high-performing models will significantly accelerate critical research areas like drug discovery and vaccine development.
The AI Powering Scientific Discovery
Claude Sonnet 4.5 scored 0.83 on the Protocol QA benchmark, surpassing a human baseline of 0.79 and Sonnet 4's previous 0.74, according to Anthropic. Claude Sonnet 4.5's score of 0.83 marks a clear improvement in understanding and responding to complex procedural questions, exceeding human averages in this specific task.
Claude Opus 4.5 ranks #5 out of 124 models in mathematics benchmarks with an average score of 94.9, according to BenchLM. Claude Opus 4.5's strong performance in mathematical reasoning establishes a robust foundation for scientific calculations and data analysis, critical for fields demanding precise quantitative methods.
The benchmark results for Claude's underlying models in mathematics and protocol understanding reveal the platform's core strength in complex scientific reasoning. While Northeastern Global News highlights the broad integration of 'over 60 scientific databases and computation tools,' these specific model performances pinpoint the disruptive power. The platform's true AI advantage likely resides in these high-performing, specialized models, rather than uniform excellence across all integrated tools.
Competitive Edge in Scientific AI
Analyzing 490 complex scientific papers for just $26, as reported by Forbes, positions Anthropic's Claude Science as an economic earthquake. The $26 cost efficiency redefines who can afford extensive scientific literature reviews, potentially shifting power from large, well-funded institutions to individual researchers and smaller laboratories.
The 97% success rate of Basecamp Research's EDEN models in designing functional peptides, as detailed by Genetic Engineering and Biotechnology News, confirms Claude Science's capability to move beyond data processing. The platform actively generates high-efficacy scientific solutions. The platform's capability demands researchers re-evaluate AI's role from an assistant to a co-creator in areas like antibiotic design and vaccine development.
With Claude Sonnet 4.5 outperforming human baselines on the Protocol QA benchmark, as detailed by Anthropic, companies and research institutions face a new competitive imperative. Those failing to integrate AI workbenches like Claude Science risk falling behind in research speed and accuracy. AI adoption is now a necessity, not an optional enhancement, for advanced scientific inquiry.
By Q4 2026, research institutions that fail to integrate AI workbenches like Anthropic's Claude Science will likely find their discovery rates significantly outpaced by those that have embraced these tools, fundamentally reshaping the landscape of scientific innovation.
